NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsMediumNeutral
Announced Sat, 21 Jun · 09:48 IST

Neuland Laboratories Limited has informed the Exchange about Credit Rating

Credit & Debt View source PDF

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Neuland Laboratories has informed the stock exchanges that CRISIL Ratings has reaffirmed its credit ratings. The long-term rating stands at CRISIL A+/Stable, indicating high safety on long-term borrowings. The short-term rating is CRISIL A1, which is the highest category for short-term debt, signifying strong capacity to meet short-term financial commitments. The rating action in both cases is 'Reaffirmed,' meaning CRISIL sees no change in the company's credit profile since the last review.

Likely market impact

The reaffirmation signals continued financial stability and strong repayment capacity, which is neutral to mildly positive for the stock and reassuring for lenders and investors. It does not change the company's borrowing costs or credit outlook.